Status:
UNKNOWN
Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy
Lead Sponsor:
Groupe Hospitalier Pitie-Salpetriere
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Supranuclear Palsy, Progressive
Eligibility:
All Genders
30-80 years
Phase:
PHASE2
Brief Summary
The syndrome of distractibility is a behavioral disorder induced by a lesion or a dysfunction of the frontal lobe. This sign is frequent in patients with progressive supranuclear palsy (PSP), a neurod...
Eligibility Criteria
Inclusion
- Patients with PSP
- Age \> 30 years old
- Disease duration \< 5 years
- Mini mental state (MMS) \> 24
- Antisaccades %: 40-80%
Exclusion
- Other parkinsonian syndromes
- MMS \< 24
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00139373
Last Update
September 14 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre d'Investigation Clinique-HÔPITAL PITIÉ-SALPETRIERE
Paris, France, 75013